×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中... [11]
作者
刘青松 [13]
王傲莉 [13]
吴宏 [10]
王文超 [10]
齐紫平 [9]
刘小川 [8]
更多...
发表日期
2022 [1]
2020 [1]
2018 [2]
2017 [3]
2016 [5]
2015 [1]
更多...
语种
英语 [13]
出处
ONCOTARGET [5]
JOURNAL OF... [4]
EUROPEAN J... [2]
ACTA PHARM... [1]
SIGNAL TRA... [1]
资助项目
Frontier S... [4]
National N... [3]
National N... [3]
National N... [3]
National N... [3]
CASHIPS Di... [2]
更多...
资助机构
China "Tho... [5]
Chinese Ac... [5]
Anhui Prov... [4]
Frontier S... [4]
National N... [4]
"Hundred T... [3]
更多...
收录类别
SCI [13]
摘要
文献类型
期刊论文 [13]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
(本次检索基于用户作品认领结果)
浏览/检索结果:
共13条,第1-10条
帮助
限定条件
作者:王傲莉
第一作者
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
WOS被引频次升序
WOS被引频次降序
发表日期升序
发表日期降序
期刊影响因子升序
期刊影响因子降序
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
;
Li, Xi-xiang
;
Wang, Bei-lei
;
Ge, Juan
;
Zou, Feng-ming
;
Chen, Cheng
;
Wang, Jun-jie
;
Hu, Chen
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
收藏
  |  
浏览/下载:93/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5
作者:
Liu, Juan
;
Liang, Qianmao
;
Wang, Aoli
;
Zou, Fengming
;
Qi, Ziping
;
Yu, Kailin
;
Liu, Qingwang
;
Chen, Cheng
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2020/11/30
Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino) cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl) tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 158, 页码: 896-916
作者:
Wang, Beilei
;
Wu, Jiaxin
;
Wu, Yun
;
Chen, Cheng
;
Zou, Fengming
;
Wang, Aoli
;
Wu, Hong
;
Hu, Zhenquan
;
Jiang, Zongru
;
Liu, Qingwang
;
Wang, Wei
;
Zhang, Yicong
;
Liu, Feiyang
;
Zhao, Ming
;
Hu, Jie
;
Huang, Tao
;
Ge, Juan
;
Wang, Li
;
Ren, Tao
;
Wang, Yuxin
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2019/12/25
CDK9
Kinase inhibitor
Structure-activity relationship
Leukemia
Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3K delta) inhibitor
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 156, 页码: 831-846
作者:
Liang, Xiaofei
;
Li, Feng
;
Chen, Cheng
;
Jiang, Zongru
;
Wang, Aoli
;
Liu, Xiaochuan
;
Ge, Juan
;
Hu, Zhenquan
;
Yu, Kailin
;
Wang, Wenliang
;
Zou, Fengming
;
Liu, Qingwang
;
Wang, Beilei
;
Wang, Li
;
Zhang, Shanchun
;
Wang, Yuxin
;
Liu, Qingsong
;
Liu, Jing
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2019/12/10
PI3K delta
Kinase inhibitor
Acute myeloid leukemia
Structure-activity relationship
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 20, 页码: 8407-8424
作者:
Wang, Aoli
;
Li, Xixiang
;
Chen, Cheng
;
Wu, Hong
;
Qi, Ziping
;
Hu, Chen
;
Yu, Kailin
;
Wu, Jiaxin
;
Liu, Juan
;
Liu, Xiaochuan
;
Hu, Zhenquan
;
Wang, Wei
;
Wang, Wenliang
;
Wang, Wenchao
;
Wang, Li
;
Wang, Beilei
;
Liu, Qingwang
;
Li, Lili
;
Ge, Jian
;
Ren, Tao
;
Zhang, Shanchun
;
Xia, Ruixiang
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(10028Kb)
  |  
收藏
  |  
浏览/下载:78/31
  |  
提交时间:2019/06/17
Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl5-(3,4,5-trimethoxybenzamido)phenyI)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 5, 页码: 1793-1816
作者:
Liang, Xiaofei
;
Lv, Fengchao
;
Wang, Beilei
;
Yu, Kailin
;
Wu, Hong
;
Qi, Ziping
;
Jiang, Zongru
;
Chen, Cheng
;
Wang, Aoli
;
Miao, Weili
;
Wang, Wenchao
;
Hu, Zhenquan
;
Liu, Juan
;
Liu, Xiaochuan
;
Zhao, Zheng
;
Wang, Li
;
Zhang, Shanchuan
;
Ye, Zi
;
Wang, Chu
;
Ren, Tao
;
Wang, Yinsheng
;
Liu, Qingsong
;
Liu, Jing
浏览
  |  
Adobe PDF(5919Kb)
  |  
收藏
  |  
浏览/下载:17292/7523
  |  
提交时间:2018/07/04
Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 11, 页码: 18359-18372
作者:
Hu, Chen
;
Wang, Aoli
;
Wu, Hong
;
Qi, Ziping
;
Li, Xixiang
;
Yan, Xiao-E
;
Chen, Cheng
;
Yu, Kailin
;
Zou, Fengming
;
Wang, Wenchao
;
Wang, Wei
;
Wu, Jiaxin
;
Liu, Juan
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shanchun
;
Yun, Cai-Hong
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(6153Kb)
  |  
收藏
  |  
浏览/下载:177/46
  |  
提交时间:2018/07/04
Egfr
Egfrt790m
Nsclc
Kinase Inhibitors
Drug Resistance
Discovery of N-((1-(4-(3-(3-((6,7-Dimethoxyquinolin-3-yl)oxy)phenyl)ureido)-2-(trifluoromethyl)phenyl)piperidin-4-yl)methyl)propionamide (CHMFL-KIT-8140) as a Highly Potent Type II Inhibitor Capable of Inhibiting the T670I "Gatekeeper" Mutant of cKIT Kinase
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 59, 期号: 18, 页码: 8456-8472
作者:
Li, Binhua
;
Wang, Aoli
;
Liu, Juan
;
Qi, Ziping
;
Liu, Xiaochuan
;
Yu, Kailin
;
Wu, Hong
;
Chen, Cheng
;
Hu, Chen
;
Wang, Wenchao
;
Wu, Jiaxin
;
Hu, Zhenquan
;
Ye, Ling
;
Zou, Fengming
;
Liu, Feiyang
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shaojuan
;
Bai, Mingfeng
;
Zhang, Shanchun
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(2856Kb)
  |  
收藏
  |  
浏览/下载:1401/1298
  |  
提交时间:2017/11/21
Simultaneous inhibition of Vps34 kinase would enhance PI3K delta inhibitor cytotoxicity in the B-cell malignancies
期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 33, 页码: 53515-53525
作者:
Liu, Xiaochuan
;
Wang, Aoli
;
Liang, Xiaofei
;
Liu, Juanjuan
;
Zou, Fengming
;
Chen, Cheng
;
Zhao, Zheng
;
Deng, Yuanxin
;
Wu, Hong
;
Qi, Ziping
;
Wang, Beilei
;
Wang, Li
;
Liu, Feiyang
;
Xu, Yunhe
;
Wang, Wenchao
;
Fernandes, Stacey M.
;
Stone, Richard M.
;
Galinsky, Ilene A.
;
Brown, Jennifer R.
;
Loh, Teckpeng
;
Griffin, James. D.
;
Zhang, Shanchun
;
Weisberg, Ellen L.
;
Zhang, Xin
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(7625Kb)
  |  
收藏
  |  
浏览/下载:94/37
  |  
提交时间:2017/11/21
Pi3k Delta
Vps34
Combination
Chronic Lymphatic Leukemia
Acute Myeloid Leukemia
Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML)
期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 29, 页码: 45562-45574
作者:
Liu, Feiyang
;
Wang, Beilei
;
Wang, Qiang
;
Qi, Ziping
;
Chen, Cheng
;
Kong, Lu-Lu
;
Chen, Ji-Yun
;
Liu, Xiaochuan
;
Wang, Aoli
;
Hu, Chen
;
Wang, Wenchao
;
Wang, Huiping
;
Wu, Fan
;
Ruan, Yanjie
;
Qi, Shuang
;
Liu, Juan
;
Zou, Fengming
;
Hu, Zhenquan
;
Wang, Wei
;
Wang, Li
;
Zhang, Shanchun
;
Yun, Cai-Hong
;
Zhai, Zhimin
;
Liu, Jing
;
Liu, Qingsong
浏览
  |  
Adobe PDF(8054Kb)
  |  
收藏
  |  
浏览/下载:246/195
  |  
提交时间:2017/11/21
Bcr-abl
Pdgfr
Chronic Myeloid Leukemia
Kinase Inhibitor